Looking back, moving forward: the evolution of cancer survivorship care

Affiliations

¹ Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA, USA.
² Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA, USA. Electronic address: ann_partridge@dfci.harvard.edu.

Comment

Shoshana M Rosenberg et al. Lancet Oncol. 2017 Jan.

. 2017 Jan;18(1):18-19.

doi: 10.1016/S1470-2045(16)30649-0.

¹ Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA, USA.
² Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA, USA. Electronic address: ann_partridge@dfci.harvard.edu.

No abstract available

Comment on

Defining cancer survivors, their needs, and perspectives on survivorship health care in the USA.
Mayer DK, Nasso SF, Earp JA. Mayer DK, et al. Lancet Oncol. 2017 Jan;18(1):e11-e18. doi: 10.1016/S1470-2045(16)30573-3. Lancet Oncol. 2017. PMID: 28049573 Review.
Follow-up care of cancer survivors: challenges and solutions.
Jacobs LA, Shulman LN. Jacobs LA, et al. Lancet Oncol. 2017 Jan;18(1):e19-e29. doi: 10.1016/S1470-2045(16)30386-2. Lancet Oncol. 2017. PMID: 28049574 Review.
Integrating primary care providers in the care of cancer survivors: gaps in evidence and future opportunities.
Nekhlyudov L, O'malley DM, Hudson SV. Nekhlyudov L, et al. Lancet Oncol. 2017 Jan;18(1):e30-e38. doi: 10.1016/S1470-2045(16)30570-8. Lancet Oncol. 2017. PMID: 28049575 Free PMC article. Review.
Provision of integrated psychosocial services for cancer survivors post-treatment.
Recklitis CJ, Syrjala KL. Recklitis CJ, et al. Lancet Oncol. 2017 Jan;18(1):e39-e50. doi: 10.1016/S1470-2045(16)30659-3. Lancet Oncol. 2017. PMID: 28049576 Free PMC article. Review.
Evaluation of effectiveness of survivorship programmes: how to measure success?
Halpern MT, Argenbright KE. Halpern MT, et al. Lancet Oncol. 2017 Jan;18(1):e51-e59. doi: 10.1016/S1470-2045(16)30563-0. Lancet Oncol. 2017. PMID: 28049577 Review.